| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 150 | 2024 | 4673 | 5.360 |
Why?
|
| Heart Transplantation | 46 | 2024 | 3258 | 4.220 |
Why?
|
| Cardiac Surgical Procedures | 77 | 2024 | 3627 | 2.910 |
Why?
|
| Tetralogy of Fallot | 24 | 2024 | 618 | 1.810 |
Why?
|
| Hospital Mortality | 42 | 2024 | 5295 | 1.700 |
Why?
|
| Infant | 225 | 2024 | 36170 | 1.610 |
Why?
|
| Fontan Procedure | 25 | 2023 | 796 | 1.520 |
Why?
|
| Waiting Lists | 10 | 2015 | 766 | 1.480 |
Why?
|
| Heart Ventricles | 42 | 2024 | 3813 | 1.480 |
Why?
|
| Norwood Procedures | 11 | 2023 | 192 | 1.460 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 17 | 2023 | 536 | 1.450 |
Why?
|
| Graft Survival | 14 | 2024 | 3843 | 1.440 |
Why?
|
| Hypoplastic Left Heart Syndrome | 19 | 2023 | 594 | 1.440 |
Why?
|
| Heart Septal Defects, Ventricular | 16 | 2024 | 477 | 1.360 |
Why?
|
| Echocardiography | 51 | 2024 | 5006 | 1.290 |
Why?
|
| Child, Preschool | 193 | 2024 | 42225 | 1.260 |
Why?
|
| Child | 239 | 2024 | 80154 | 1.190 |
Why?
|
| Retrospective Studies | 214 | 2024 | 80675 | 1.160 |
Why?
|
| Transposition of Great Vessels | 14 | 2023 | 580 | 1.160 |
Why?
|
| Pulmonary Valve | 13 | 2024 | 411 | 1.100 |
Why?
|
| Infant, Newborn | 151 | 2024 | 26200 | 1.090 |
Why?
|
| Aortic Coarctation | 12 | 2021 | 275 | 1.070 |
Why?
|
| Aortic Valve Insufficiency | 10 | 2023 | 576 | 1.070 |
Why?
|
| Tissue and Organ Procurement | 8 | 2022 | 963 | 1.030 |
Why?
|
| Heart Valve Prosthesis Implantation | 16 | 2022 | 1555 | 0.940 |
Why?
|
| Adolescent | 194 | 2024 | 88300 | 0.930 |
Why?
|
| Pulmonary Valve Stenosis | 9 | 2023 | 164 | 0.910 |
Why?
|
| Risk Assessment | 61 | 2024 | 24022 | 0.890 |
Why?
|
| Postoperative Complications | 48 | 2024 | 15637 | 0.890 |
Why?
|
| Graft Rejection | 14 | 2024 | 4481 | 0.860 |
Why?
|
| Quality Indicators, Health Care | 7 | 2019 | 1789 | 0.850 |
Why?
|
| Primary Graft Dysfunction | 2 | 2021 | 112 | 0.840 |
Why?
|
| Pulmonary Veins | 9 | 2023 | 743 | 0.800 |
Why?
|
| Coronary Aneurysm | 8 | 2021 | 233 | 0.790 |
Why?
|
| Plagiocephaly, Nonsynostotic | 3 | 2019 | 30 | 0.770 |
Why?
|
| Pulmonary Atresia | 10 | 2023 | 159 | 0.750 |
Why?
|
| Treatment Outcome | 125 | 2024 | 64681 | 0.730 |
Why?
|
| Orthotic Devices | 3 | 2019 | 130 | 0.720 |
Why?
|
| Hospitals, Special | 1 | 2020 | 90 | 0.700 |
Why?
|
| Risk Factors | 124 | 2024 | 74241 | 0.690 |
Why?
|
| Aorta | 12 | 2023 | 2040 | 0.690 |
Why?
|
| Male | 284 | 2024 | 360703 | 0.690 |
Why?
|
| Humans | 425 | 2024 | 761222 | 0.680 |
Why?
|
| Extracorporeal Membrane Oxygenation | 14 | 2024 | 1462 | 0.670 |
Why?
|
| Mitral Valve | 10 | 2023 | 1465 | 0.670 |
Why?
|
| Echocardiography, Doppler | 12 | 2020 | 898 | 0.670 |
Why?
|
| Pulmonary Valve Insufficiency | 6 | 2024 | 140 | 0.660 |
Why?
|
| Female | 287 | 2024 | 392552 | 0.650 |
Why?
|
| Hospitals, Pediatric | 24 | 2024 | 1862 | 0.650 |
Why?
|
| Ventricular Function, Right | 11 | 2024 | 618 | 0.630 |
Why?
|
| Heart Septal Defects, Atrial | 6 | 2023 | 451 | 0.620 |
Why?
|
| Aortic Valve | 14 | 2023 | 1959 | 0.620 |
Why?
|
| Intensive Care Units, Pediatric | 13 | 2023 | 1017 | 0.610 |
Why?
|
| Reoperation | 28 | 2023 | 4303 | 0.610 |
Why?
|
| Magnetic Resonance Imaging, Cine | 10 | 2024 | 1061 | 0.590 |
Why?
|
| Pediatric Nursing | 5 | 2019 | 104 | 0.590 |
Why?
|
| Heart Diseases | 12 | 2023 | 2795 | 0.580 |
Why?
|
| Aortic Valve Stenosis | 12 | 2023 | 2018 | 0.580 |
Why?
|
| Developing Countries | 12 | 2022 | 2863 | 0.580 |
Why?
|
| Ventricular Dysfunction, Left | 11 | 2024 | 2131 | 0.570 |
Why?
|
| Pulmonary Artery | 16 | 2023 | 1929 | 0.570 |
Why?
|
| Heart Valve Prosthesis | 8 | 2020 | 1463 | 0.560 |
Why?
|
| Bioprosthesis | 7 | 2019 | 591 | 0.550 |
Why?
|
| Time Factors | 63 | 2024 | 39957 | 0.550 |
Why?
|
| Connective Tissue Diseases | 5 | 2021 | 285 | 0.540 |
Why?
|
| Risk Adjustment | 11 | 2024 | 601 | 0.540 |
Why?
|
| Survivors | 7 | 2024 | 2369 | 0.540 |
Why?
|
| Young Adult | 92 | 2024 | 59222 | 0.530 |
Why?
|
| Length of Stay | 24 | 2024 | 6417 | 0.520 |
Why?
|
| Cardiomyopathy, Dilated | 5 | 2015 | 832 | 0.520 |
Why?
|
| Aftercare | 9 | 2023 | 913 | 0.500 |
Why?
|
| Supine Position | 2 | 2016 | 205 | 0.490 |
Why?
|
| Cardiomyopathies | 4 | 2024 | 2021 | 0.490 |
Why?
|
| Neonatal Nursing | 1 | 2015 | 22 | 0.480 |
Why?
|
| Heart Septal Defects | 4 | 2020 | 190 | 0.480 |
Why?
|
| Tachycardia, Ventricular | 8 | 2020 | 1305 | 0.470 |
Why?
|
| Immunoglobulins, Intravenous | 7 | 2023 | 668 | 0.460 |
Why?
|
| Hemodynamics | 27 | 2024 | 4165 | 0.460 |
Why?
|
| Cardiopulmonary Bypass | 8 | 2023 | 1092 | 0.450 |
Why?
|
| Age Factors | 35 | 2024 | 18384 | 0.440 |
Why?
|
| United States | 66 | 2024 | 72341 | 0.440 |
Why?
|
| Survival Rate | 29 | 2020 | 12728 | 0.430 |
Why?
|
| Multivariate Analysis | 37 | 2020 | 12052 | 0.430 |
Why?
|
| Follow-Up Studies | 68 | 2023 | 39127 | 0.420 |
Why?
|
| Palliative Care | 17 | 2021 | 3599 | 0.420 |
Why?
|
| Pericardium | 5 | 2022 | 674 | 0.420 |
Why?
|
| Registries | 25 | 2023 | 8246 | 0.410 |
Why?
|
| Atrioventricular Block | 2 | 2024 | 133 | 0.390 |
Why?
|
| Coronary Vessel Anomalies | 5 | 2023 | 307 | 0.390 |
Why?
|
| Ventricular Dysfunction, Right | 7 | 2018 | 629 | 0.380 |
Why?
|
| Personnel Staffing and Scheduling | 4 | 2019 | 495 | 0.380 |
Why?
|
| Discrete Subaortic Stenosis | 3 | 2020 | 16 | 0.380 |
Why?
|
| Constriction, Pathologic | 11 | 2023 | 1097 | 0.380 |
Why?
|
| Accessory Atrioventricular Bundle | 2 | 2023 | 58 | 0.380 |
Why?
|
| Nursing Staff, Hospital | 5 | 2019 | 348 | 0.370 |
Why?
|
| Heart Valve Diseases | 4 | 2023 | 1031 | 0.370 |
Why?
|
| Boston | 28 | 2023 | 9327 | 0.370 |
Why?
|
| Quality Improvement | 15 | 2021 | 3808 | 0.370 |
Why?
|
| Heart Failure | 16 | 2023 | 11701 | 0.370 |
Why?
|
| Heart Atria | 4 | 2023 | 1349 | 0.370 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2023 | 1400 | 0.360 |
Why?
|
| Patient Discharge | 13 | 2023 | 3441 | 0.360 |
Why?
|
| Angioplasty, Balloon | 6 | 2013 | 589 | 0.360 |
Why?
|
| Exercise Test | 13 | 2024 | 2165 | 0.350 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 2023 | 116 | 0.350 |
Why?
|
| Databases, Factual | 19 | 2021 | 7965 | 0.350 |
Why?
|
| Adult | 116 | 2024 | 221120 | 0.350 |
Why?
|
| Glomerular Filtration Rate | 2 | 2018 | 2182 | 0.340 |
Why?
|
| Coronary Vessels | 10 | 2021 | 3111 | 0.330 |
Why?
|
| Fetal Diseases | 4 | 2023 | 912 | 0.330 |
Why?
|
| Ventricular Function, Left | 9 | 2020 | 3899 | 0.320 |
Why?
|
| Data Interpretation, Statistical | 4 | 2008 | 2691 | 0.320 |
Why?
|
| Predictive Value of Tests | 27 | 2024 | 15308 | 0.320 |
Why?
|
| Aortic Aneurysm | 3 | 2021 | 648 | 0.310 |
Why?
|
| Tricuspid Atresia | 3 | 2015 | 37 | 0.310 |
Why?
|
| Hospital Charges | 6 | 2021 | 350 | 0.300 |
Why?
|
| Pacemaker, Artificial | 3 | 2023 | 807 | 0.300 |
Why?
|
| Stents | 9 | 2023 | 3177 | 0.290 |
Why?
|
| Prosthesis Failure | 4 | 2019 | 1204 | 0.290 |
Why?
|
| Aorta, Thoracic | 7 | 2023 | 1096 | 0.290 |
Why?
|
| Ventricular Function | 4 | 2016 | 406 | 0.290 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2022 | 1312 | 0.290 |
Why?
|
| Odds Ratio | 25 | 2021 | 9652 | 0.290 |
Why?
|
| Dilatation, Pathologic | 10 | 2023 | 527 | 0.280 |
Why?
|
| Postoperative Period | 11 | 2018 | 1818 | 0.270 |
Why?
|
| Mitral Valve Stenosis | 3 | 2023 | 341 | 0.270 |
Why?
|
| Prognosis | 33 | 2023 | 29688 | 0.270 |
Why?
|
| Malnutrition | 3 | 2024 | 622 | 0.270 |
Why?
|
| Logistic Models | 25 | 2022 | 13249 | 0.270 |
Why?
|
| Cardiovascular Surgical Procedures | 3 | 2015 | 190 | 0.270 |
Why?
|
| Catheterization | 6 | 2023 | 1428 | 0.260 |
Why?
|
| Double Outlet Right Ventricle | 3 | 2022 | 60 | 0.260 |
Why?
|
| Kidney Diseases | 2 | 2014 | 2092 | 0.260 |
Why?
|
| Statistics as Topic | 3 | 2006 | 2359 | 0.260 |
Why?
|
| Severity of Illness Index | 22 | 2023 | 15841 | 0.260 |
Why?
|
| Myocarditis | 3 | 2023 | 792 | 0.260 |
Why?
|
| Exercise Tolerance | 2 | 2008 | 838 | 0.260 |
Why?
|
| Defibrillators, Implantable | 5 | 2022 | 1492 | 0.260 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2020 | 513 | 0.250 |
Why?
|
| Ventricular Septum | 2 | 2023 | 76 | 0.250 |
Why?
|
| Exercise | 8 | 2024 | 5874 | 0.250 |
Why?
|
| Kaplan-Meier Estimate | 13 | 2019 | 6486 | 0.240 |
Why?
|
| Terminal Care | 4 | 2023 | 1760 | 0.240 |
Why?
|
| Health Resources | 5 | 2015 | 934 | 0.240 |
Why?
|
| Cause of Death | 11 | 2021 | 3688 | 0.240 |
Why?
|
| Heart Rate | 4 | 2020 | 4197 | 0.240 |
Why?
|
| Decision Support Techniques | 5 | 2023 | 2004 | 0.240 |
Why?
|
| Patient Compliance | 3 | 2023 | 2688 | 0.240 |
Why?
|
| Catheter Ablation | 3 | 2023 | 2751 | 0.230 |
Why?
|
| Clinical Competence | 10 | 2016 | 4788 | 0.230 |
Why?
|
| Health Status Disparities | 2 | 2019 | 1847 | 0.230 |
Why?
|
| Social Class | 3 | 2023 | 1993 | 0.230 |
Why?
|
| Heart | 6 | 2023 | 4431 | 0.230 |
Why?
|
| Heart Bypass, Right | 4 | 2018 | 75 | 0.230 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 3 | 2013 | 64 | 0.230 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3354 | 0.220 |
Why?
|
| Intensive Care Units, Neonatal | 5 | 2019 | 845 | 0.220 |
Why?
|
| Ultrafiltration | 1 | 2023 | 48 | 0.220 |
Why?
|
| Stroke Volume | 14 | 2024 | 5521 | 0.220 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2022 | 2247 | 0.220 |
Why?
|
| Socioeconomic Factors | 10 | 2023 | 7804 | 0.220 |
Why?
|
| Truncus Arteriosus, Persistent | 2 | 2023 | 63 | 0.220 |
Why?
|
| Magnetic Resonance Angiography | 6 | 2021 | 1432 | 0.220 |
Why?
|
| Hypertension, Pulmonary | 3 | 2024 | 1592 | 0.210 |
Why?
|
| Malus | 1 | 2023 | 50 | 0.210 |
Why?
|
| Incidence | 23 | 2021 | 21366 | 0.210 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2021 | 866 | 0.210 |
Why?
|
| Thrombosis | 5 | 2023 | 2944 | 0.210 |
Why?
|
| Epidemiologic Research Design | 1 | 2006 | 368 | 0.210 |
Why?
|
| Echocardiography, Stress | 2 | 2022 | 135 | 0.210 |
Why?
|
| Ventricular Premature Complexes | 1 | 2024 | 112 | 0.210 |
Why?
|
| Aortic Diseases | 3 | 2023 | 735 | 0.210 |
Why?
|
| Equipment Design | 6 | 2019 | 3510 | 0.210 |
Why?
|
| Immunosuppressive Agents | 4 | 2023 | 4190 | 0.210 |
Why?
|
| Infant, Premature | 8 | 2023 | 2106 | 0.200 |
Why?
|
| Population Surveillance | 3 | 2018 | 2598 | 0.200 |
Why?
|
| Postoperative Care | 5 | 2020 | 1468 | 0.200 |
Why?
|
| Scimitar Syndrome | 1 | 2022 | 30 | 0.200 |
Why?
|
| Vein of Galen Malformations | 1 | 2023 | 58 | 0.200 |
Why?
|
| Oxygen Consumption | 7 | 2023 | 1867 | 0.200 |
Why?
|
| Coronary Artery Disease | 6 | 2022 | 6506 | 0.200 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2478 | 0.200 |
Why?
|
| Recovery of Function | 6 | 2015 | 2981 | 0.200 |
Why?
|
| Ventricular Remodeling | 3 | 2015 | 1270 | 0.200 |
Why?
|
| Chi-Square Distribution | 6 | 2015 | 3418 | 0.190 |
Why?
|
| Aortic Stenosis, Supravalvular | 2 | 2019 | 28 | 0.190 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2023 | 216 | 0.190 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2016 | 261 | 0.190 |
Why?
|
| Prospective Studies | 39 | 2022 | 54437 | 0.190 |
Why?
|
| Sick Sinus Syndrome | 1 | 2021 | 44 | 0.190 |
Why?
|
| Critical Pathways | 3 | 2016 | 475 | 0.190 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2020 | 507 | 0.190 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2022 | 148 | 0.190 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 1301 | 0.190 |
Why?
|
| Liver Cirrhosis | 3 | 2016 | 1932 | 0.180 |
Why?
|
| Tissue Donors | 4 | 2024 | 2335 | 0.180 |
Why?
|
| Diagnostic Errors | 3 | 2014 | 1265 | 0.180 |
Why?
|
| Death, Sudden, Cardiac | 5 | 2020 | 1560 | 0.180 |
Why?
|
| Proportional Hazards Models | 15 | 2017 | 12474 | 0.180 |
Why?
|
| Septal Occluder Device | 1 | 2021 | 125 | 0.180 |
Why?
|
| Intraoperative Complications | 6 | 2013 | 1164 | 0.180 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2023 | 326 | 0.180 |
Why?
|
| Cardiology | 4 | 2022 | 1693 | 0.180 |
Why?
|
| Vascular Diseases | 3 | 2015 | 1160 | 0.180 |
Why?
|
| Feasibility Studies | 8 | 2022 | 5250 | 0.170 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2022 | 353 | 0.170 |
Why?
|
| Developmental Disabilities | 5 | 2013 | 1510 | 0.170 |
Why?
|
| Fever | 3 | 2020 | 1618 | 0.170 |
Why?
|
| Conscious Sedation | 2 | 2015 | 533 | 0.170 |
Why?
|
| Infant Mortality | 4 | 2013 | 752 | 0.170 |
Why?
|
| Relative Value Scales | 3 | 2014 | 84 | 0.170 |
Why?
|
| Electrocardiography | 11 | 2020 | 6387 | 0.170 |
Why?
|
| Reproducibility of Results | 23 | 2021 | 20118 | 0.170 |
Why?
|
| Oxyhemoglobins | 3 | 2017 | 212 | 0.170 |
Why?
|
| Echocardiography, Three-Dimensional | 4 | 2014 | 607 | 0.170 |
Why?
|
| Mitral Valve Prolapse | 1 | 2021 | 212 | 0.170 |
Why?
|
| Directive Counseling | 1 | 2021 | 170 | 0.170 |
Why?
|
| Diet | 2 | 2014 | 8048 | 0.170 |
Why?
|
| Heart Arrest | 2 | 2023 | 1513 | 0.160 |
Why?
|
| Heart-Assist Devices | 5 | 2017 | 1288 | 0.160 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2019 | 27 | 0.160 |
Why?
|
| Middle Aged | 47 | 2024 | 220858 | 0.160 |
Why?
|
| Radiation, Ionizing | 1 | 2020 | 252 | 0.160 |
Why?
|
| Body Size | 1 | 2022 | 463 | 0.160 |
Why?
|
| Physical Fitness | 1 | 2023 | 742 | 0.160 |
Why?
|
| Organ Size | 2 | 2022 | 2253 | 0.160 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2018 | 22 | 0.160 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2019 | 577 | 0.160 |
Why?
|
| Critical Care | 5 | 2017 | 2696 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 2164 | 0.150 |
Why?
|
| Health Status Indicators | 3 | 2021 | 970 | 0.150 |
Why?
|
| Surgical Wound Infection | 3 | 2017 | 1530 | 0.150 |
Why?
|
| Cohort Studies | 29 | 2022 | 41496 | 0.150 |
Why?
|
| Atrial Function | 1 | 2018 | 99 | 0.150 |
Why?
|
| Models, Nursing | 1 | 2018 | 46 | 0.150 |
Why?
|
| Respiratory Dead Space | 1 | 2018 | 31 | 0.150 |
Why?
|
| Cardiac Output | 3 | 2018 | 831 | 0.150 |
Why?
|
| Survival Analysis | 17 | 2019 | 10088 | 0.150 |
Why?
|
| Child Development | 4 | 2023 | 2302 | 0.150 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2019 | 275 | 0.150 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2020 | 273 | 0.150 |
Why?
|
| Laboratories | 1 | 2021 | 462 | 0.150 |
Why?
|
| Echocardiography, Doppler, Color | 6 | 2016 | 352 | 0.150 |
Why?
|
| Prenatal Care | 2 | 2022 | 1141 | 0.150 |
Why?
|
| Prosthesis Design | 8 | 2020 | 2114 | 0.150 |
Why?
|
| Thoracic Surgery | 2 | 2023 | 722 | 0.150 |
Why?
|
| Quality of Life | 5 | 2023 | 13367 | 0.150 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2018 | 130 | 0.150 |
Why?
|
| Device Removal | 3 | 2022 | 629 | 0.140 |
Why?
|
| Prostheses and Implants | 6 | 2019 | 1273 | 0.140 |
Why?
|
| Models, Statistical | 5 | 2017 | 5081 | 0.140 |
Why?
|
| Sternotomy | 1 | 2018 | 128 | 0.140 |
Why?
|
| Cyanosis | 1 | 2017 | 82 | 0.140 |
Why?
|
| Myocardium | 5 | 2023 | 4746 | 0.140 |
Why?
|
| Blood Preservation | 1 | 2018 | 169 | 0.140 |
Why?
|
| Endocarditis, Bacterial | 2 | 2013 | 436 | 0.140 |
Why?
|
| Dilatation | 3 | 2023 | 307 | 0.140 |
Why?
|
| Patient Admission | 4 | 2022 | 1365 | 0.140 |
Why?
|
| Arteries | 2 | 2021 | 1121 | 0.140 |
Why?
|
| Current Procedural Terminology | 2 | 2014 | 89 | 0.140 |
Why?
|
| Nutritional Support | 1 | 2018 | 173 | 0.140 |
Why?
|
| Oxygen | 5 | 2018 | 4228 | 0.140 |
Why?
|
| Marfan Syndrome | 2 | 2017 | 236 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2021 | 465 | 0.140 |
Why?
|
| Myocardial Contraction | 3 | 2018 | 1516 | 0.140 |
Why?
|
| Thoracotomy | 1 | 2018 | 366 | 0.140 |
Why?
|
| Physical Exertion | 2 | 2011 | 668 | 0.130 |
Why?
|
| Rotation | 2 | 2016 | 517 | 0.130 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2018 | 144 | 0.130 |
Why?
|
| Early Diagnosis | 3 | 2016 | 1186 | 0.130 |
Why?
|
| Diagnosis-Related Groups | 4 | 2014 | 448 | 0.130 |
Why?
|
| Blood Gas Analysis | 1 | 2017 | 379 | 0.130 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 304 | 0.130 |
Why?
|
| Coronary Thrombosis | 2 | 2010 | 440 | 0.130 |
Why?
|
| Single-Blind Method | 3 | 2015 | 1577 | 0.130 |
Why?
|
| Hyperoxia | 1 | 2018 | 259 | 0.130 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2016 | 85 | 0.130 |
Why?
|
| Observer Variation | 10 | 2016 | 2610 | 0.130 |
Why?
|
| Recurrence | 10 | 2022 | 8457 | 0.130 |
Why?
|
| ROC Curve | 8 | 2020 | 3584 | 0.130 |
Why?
|
| Preventive Health Services | 1 | 2021 | 567 | 0.130 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 619 | 0.130 |
Why?
|
| Employee Performance Appraisal | 1 | 2016 | 86 | 0.130 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 385 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 3 | 2022 | 1489 | 0.130 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 991 | 0.130 |
Why?
|
| Tricuspid Valve | 3 | 2022 | 410 | 0.130 |
Why?
|
| Nutritional Status | 3 | 2024 | 1597 | 0.120 |
Why?
|
| Case-Control Studies | 15 | 2020 | 22174 | 0.120 |
Why?
|
| Goals | 1 | 2020 | 710 | 0.120 |
Why?
|
| Analysis of Variance | 7 | 2017 | 6223 | 0.120 |
Why?
|
| Cross-Sectional Studies | 19 | 2023 | 26072 | 0.120 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2015 | 30 | 0.120 |
Why?
|
| Head Protective Devices | 1 | 2016 | 118 | 0.120 |
Why?
|
| Creatinine | 3 | 2018 | 1897 | 0.120 |
Why?
|
| Aneurysm, False | 1 | 2017 | 255 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 1232 | 0.120 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2017 | 1425 | 0.120 |
Why?
|
| Atenolol | 1 | 2015 | 99 | 0.120 |
Why?
|
| Certification | 1 | 2018 | 418 | 0.120 |
Why?
|
| Health Care Surveys | 5 | 2016 | 2425 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 18 | 2024 | 36415 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2022 | 1757 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 210 | 0.120 |
Why?
|
| Income | 5 | 2022 | 1869 | 0.120 |
Why?
|
| Critical Illness | 5 | 2016 | 2724 | 0.120 |
Why?
|
| Oximetry | 1 | 2017 | 459 | 0.120 |
Why?
|
| International Cooperation | 2 | 2019 | 1423 | 0.110 |
Why?
|
| Milrinone | 1 | 2014 | 86 | 0.110 |
Why?
|
| Tendons | 1 | 2018 | 558 | 0.110 |
Why?
|
| Bundle of His | 2 | 2024 | 101 | 0.110 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 540 | 0.110 |
Why?
|
| Heparin | 2 | 2013 | 1632 | 0.110 |
Why?
|
| Pressure Ulcer | 1 | 2015 | 157 | 0.110 |
Why?
|
| Fetal Death | 2 | 2015 | 435 | 0.110 |
Why?
|
| Gestational Age | 6 | 2015 | 3580 | 0.110 |
Why?
|
| Laboratories, Hospital | 1 | 2015 | 192 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2019 | 1436 | 0.110 |
Why?
|
| Pediatrics | 6 | 2021 | 3590 | 0.110 |
Why?
|
| Aortic Arch Syndromes | 2 | 2007 | 19 | 0.110 |
Why?
|
| Pharmacology, Clinical | 1 | 1993 | 22 | 0.110 |
Why?
|
| Probability | 9 | 2013 | 2478 | 0.110 |
Why?
|
| Electric Countershock | 2 | 2014 | 533 | 0.110 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 1994 | 186 | 0.110 |
Why?
|
| Catheterization, Peripheral | 2 | 2013 | 343 | 0.110 |
Why?
|
| Losartan | 1 | 2015 | 263 | 0.110 |
Why?
|
| Coronary Angiography | 7 | 2022 | 4507 | 0.110 |
Why?
|
| Noonan Syndrome | 1 | 2014 | 120 | 0.110 |
Why?
|
| Cephalometry | 1 | 2015 | 377 | 0.110 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 569 | 0.110 |
Why?
|
| Contrast Media | 3 | 2018 | 5311 | 0.100 |
Why?
|
| Hyaluronic Acid | 1 | 2016 | 484 | 0.100 |
Why?
|
| Morbidity | 5 | 2023 | 1751 | 0.100 |
Why?
|
| Cesarean Section | 2 | 2012 | 1399 | 0.100 |
Why?
|
| Triglycerides | 2 | 2019 | 2457 | 0.100 |
Why?
|
| Sex Factors | 7 | 2019 | 10553 | 0.100 |
Why?
|
| Ventricular Dysfunction | 3 | 2016 | 144 | 0.100 |
Why?
|
| Clinical Medicine | 1 | 1994 | 145 | 0.100 |
Why?
|
| Benchmarking | 2 | 2016 | 1045 | 0.100 |
Why?
|
| Angioplasty | 2 | 2013 | 356 | 0.100 |
Why?
|
| Sirolimus | 1 | 2019 | 1540 | 0.100 |
Why?
|
| Disease Management | 3 | 2018 | 2507 | 0.100 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2018 | 558 | 0.100 |
Why?
|
| Swine | 5 | 2022 | 5909 | 0.100 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2012 | 61 | 0.100 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 431 | 0.100 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2011 | 22 | 0.100 |
Why?
|
| Prevalence | 10 | 2024 | 15721 | 0.100 |
Why?
|
| Natural Childbirth | 1 | 2011 | 15 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2019 | 870 | 0.100 |
Why?
|
| Drug Evaluation | 1 | 1993 | 641 | 0.100 |
Why?
|
| Respiration, Artificial | 7 | 2018 | 2631 | 0.100 |
Why?
|
| Referral and Consultation | 2 | 2021 | 3608 | 0.100 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2005 | 749 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1878 | 0.090 |
Why?
|
| Heart Septum | 4 | 2015 | 301 | 0.090 |
Why?
|
| Operating Room Nursing | 1 | 2011 | 25 | 0.090 |
Why?
|
| Labor Presentation | 1 | 2011 | 55 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2016 | 869 | 0.090 |
Why?
|
| Ultrasonography | 11 | 2020 | 5969 | 0.090 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2012 | 61 | 0.090 |
Why?
|
| Abnormalities, Multiple | 4 | 2017 | 1423 | 0.090 |
Why?
|
| Family | 1 | 2022 | 3192 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 2 | 2020 | 1178 | 0.090 |
Why?
|
| Algorithms | 7 | 2019 | 14025 | 0.090 |
Why?
|
| Pilot Projects | 7 | 2022 | 8642 | 0.090 |
Why?
|
| Cardiovascular Diseases | 4 | 2021 | 15521 | 0.090 |
Why?
|
| ABO Blood-Group System | 2 | 2010 | 381 | 0.090 |
Why?
|
| Disease-Free Survival | 4 | 2015 | 6819 | 0.090 |
Why?
|
| Biometry | 1 | 1994 | 563 | 0.090 |
Why?
|
| Caregivers | 1 | 2022 | 2244 | 0.090 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2010 | 20 | 0.090 |
Why?
|
| Heart Block | 3 | 2022 | 385 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2010 | 1812 | 0.090 |
Why?
|
| Vertebral Artery | 1 | 2011 | 184 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2014 | 941 | 0.090 |
Why?
|
| Nervous System | 1 | 2013 | 545 | 0.090 |
Why?
|
| Vinblastine | 1 | 2011 | 488 | 0.090 |
Why?
|
| Preoperative Period | 3 | 2020 | 551 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5666 | 0.090 |
Why?
|
| Diet, Reducing | 1 | 1993 | 485 | 0.090 |
Why?
|
| Child Mortality | 1 | 2012 | 199 | 0.090 |
Why?
|
| Linear Models | 7 | 2019 | 5869 | 0.090 |
Why?
|
| Troponin | 2 | 2023 | 504 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 1869 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 2 | 2012 | 1923 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2019 | 6345 | 0.080 |
Why?
|
| Aged | 16 | 2019 | 169292 | 0.080 |
Why?
|
| Triage | 1 | 2016 | 985 | 0.080 |
Why?
|
| Liver | 2 | 2016 | 7512 | 0.080 |
Why?
|
| Fetus | 1 | 2017 | 1864 | 0.080 |
Why?
|
| Calcinosis | 2 | 2017 | 1477 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 4 | 2008 | 2725 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2009 | 123 | 0.080 |
Why?
|
| Nursing Staff | 1 | 2010 | 113 | 0.080 |
Why?
|
| Histocompatibility | 1 | 2010 | 319 | 0.080 |
Why?
|
| HIV Seropositivity | 1 | 1994 | 957 | 0.080 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2014 | 389 | 0.080 |
Why?
|
| Head | 1 | 2015 | 922 | 0.080 |
Why?
|
| Pulse | 1 | 2009 | 218 | 0.080 |
Why?
|
| Age Distribution | 5 | 2018 | 2871 | 0.080 |
Why?
|
| Anxiety | 3 | 2022 | 4569 | 0.080 |
Why?
|
| Quality of Health Care | 4 | 2009 | 4321 | 0.080 |
Why?
|
| Leadership | 1 | 2018 | 1385 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2018 | 2413 | 0.080 |
Why?
|
| C-Reactive Protein | 5 | 2021 | 3821 | 0.080 |
Why?
|
| Blood Pressure | 6 | 2019 | 8479 | 0.080 |
Why?
|
| Intracranial Aneurysm | 1 | 2018 | 1286 | 0.080 |
Why?
|
| Biopsy | 5 | 2020 | 6781 | 0.080 |
Why?
|
| Medical Records | 1 | 2014 | 1409 | 0.080 |
Why?
|
| Weight Gain | 1 | 2018 | 2349 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3331 | 0.080 |
Why?
|
| Body Temperature | 1 | 2011 | 780 | 0.080 |
Why?
|
| Intensive Care Units | 4 | 2024 | 3744 | 0.080 |
Why?
|
| Analgesia, Epidural | 1 | 2011 | 332 | 0.070 |
Why?
|
| Death | 2 | 2023 | 677 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 2047 | 0.070 |
Why?
|
| Anesthesia, General | 1 | 2015 | 1174 | 0.070 |
Why?
|
| Specialization | 1 | 2013 | 778 | 0.070 |
Why?
|
| Hyperglycemia | 2 | 2008 | 1375 | 0.070 |
Why?
|
| Friedreich Ataxia | 1 | 2008 | 77 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 488 | 0.070 |
Why?
|
| Cross Infection | 1 | 2017 | 1422 | 0.070 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2009 | 1086 | 0.070 |
Why?
|
| Situs Inversus | 1 | 2007 | 63 | 0.070 |
Why?
|
| Hypertension | 5 | 2023 | 8536 | 0.070 |
Why?
|
| Neuromuscular Blockade | 1 | 2009 | 147 | 0.070 |
Why?
|
| Residence Characteristics | 3 | 2019 | 2092 | 0.070 |
Why?
|
| Safety Management | 1 | 2013 | 761 | 0.070 |
Why?
|
| Models, Cardiovascular | 2 | 2007 | 983 | 0.070 |
Why?
|
| Foreign-Body Reaction | 3 | 2017 | 157 | 0.070 |
Why?
|
| Exercise Therapy | 2 | 2022 | 922 | 0.070 |
Why?
|
| Sudden Infant Death | 1 | 2010 | 292 | 0.070 |
Why?
|
| Life Style | 1 | 2019 | 3907 | 0.070 |
Why?
|
| Mortality | 2 | 2016 | 2896 | 0.070 |
Why?
|
| Perfusion | 3 | 2007 | 1390 | 0.070 |
Why?
|
| Rheumatic Fever | 1 | 2007 | 73 | 0.070 |
Why?
|
| Systole | 3 | 2016 | 936 | 0.070 |
Why?
|
| Pregnancy | 9 | 2022 | 29893 | 0.070 |
Why?
|
| Age of Onset | 4 | 2021 | 3307 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2014 | 1185 | 0.070 |
Why?
|
| Statistical Distributions | 1 | 2006 | 63 | 0.070 |
Why?
|
| Workload | 3 | 2019 | 845 | 0.070 |
Why?
|
| Body Weight | 3 | 2013 | 4618 | 0.070 |
Why?
|
| Lymphatic System | 1 | 2008 | 253 | 0.070 |
Why?
|
| Protein-Losing Enteropathies | 2 | 2008 | 45 | 0.070 |
Why?
|
| Sepsis | 2 | 2019 | 2585 | 0.070 |
Why?
|
| Veins | 2 | 2023 | 767 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2013 | 1302 | 0.070 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2006 | 82 | 0.070 |
Why?
|
| Cardiac Volume | 1 | 2007 | 197 | 0.070 |
Why?
|
| Hospitalization | 6 | 2021 | 10707 | 0.070 |
Why?
|
| Drug Therapy, Combination | 4 | 2020 | 6304 | 0.070 |
Why?
|
| Inpatients | 3 | 2013 | 2545 | 0.070 |
Why?
|
| Vena Cava, Superior | 2 | 2006 | 196 | 0.070 |
Why?
|
| Chorea | 2 | 2007 | 79 | 0.070 |
Why?
|
| Nervous System Diseases | 2 | 2009 | 1663 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1720 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1379 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 1923 | 0.070 |
Why?
|
| Data Collection | 2 | 2009 | 3320 | 0.070 |
Why?
|
| California | 3 | 2019 | 1431 | 0.070 |
Why?
|
| Transplantation, Homologous | 5 | 2020 | 4822 | 0.070 |
Why?
|
| Eye Injuries | 1 | 2009 | 227 | 0.060 |
Why?
|
| Angiography | 1 | 2011 | 1597 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1994 | 2196 | 0.060 |
Why?
|
| Depression | 4 | 2014 | 8132 | 0.060 |
Why?
|
| Propanolamines | 1 | 2006 | 163 | 0.060 |
Why?
|
| Williams Syndrome | 2 | 2013 | 194 | 0.060 |
Why?
|
| Enteral Nutrition | 2 | 2009 | 794 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 1725 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2008 | 366 | 0.060 |
Why?
|
| Medical Errors | 1 | 2014 | 1263 | 0.060 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2006 | 189 | 0.060 |
Why?
|
| Aortic Rupture | 1 | 2008 | 319 | 0.060 |
Why?
|
| Disease Progression | 8 | 2022 | 13511 | 0.060 |
Why?
|
| Intraoperative Care | 1 | 2009 | 767 | 0.060 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2004 | 10 | 0.060 |
Why?
|
| Foramen Ovale, Patent | 1 | 2007 | 208 | 0.060 |
Why?
|
| Liver Function Tests | 2 | 2016 | 525 | 0.060 |
Why?
|
| Methotrexate | 1 | 2011 | 1718 | 0.060 |
Why?
|
| Anticoagulants | 3 | 2023 | 4795 | 0.060 |
Why?
|
| Fetal Heart | 1 | 2006 | 281 | 0.060 |
Why?
|
| Sensitivity and Specificity | 9 | 2014 | 14675 | 0.060 |
Why?
|
| Carbazoles | 1 | 2006 | 220 | 0.060 |
Why?
|
| North America | 2 | 2019 | 1284 | 0.060 |
Why?
|
| Delivery, Obstetric | 1 | 2012 | 941 | 0.060 |
Why?
|
| Heart Function Tests | 3 | 2015 | 318 | 0.060 |
Why?
|
| Drug Administration Schedule | 4 | 2018 | 4851 | 0.060 |
Why?
|
| National Health Programs | 1 | 2007 | 440 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2010 | 1589 | 0.060 |
Why?
|
| Neuropsychological Tests | 3 | 2013 | 7046 | 0.060 |
Why?
|
| Prenatal Diagnosis | 2 | 2022 | 1267 | 0.060 |
Why?
|
| Ticlopidine | 1 | 2008 | 730 | 0.060 |
Why?
|
| Triiodothyronine | 1 | 2005 | 492 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 10218 | 0.060 |
Why?
|
| Statistics, Nonparametric | 5 | 2008 | 2854 | 0.050 |
Why?
|
| Sex Distribution | 4 | 2012 | 2277 | 0.050 |
Why?
|
| Ductus Arteriosus | 1 | 2023 | 42 | 0.050 |
Why?
|
| Life Tables | 4 | 2006 | 364 | 0.050 |
Why?
|
| Truncus Arteriosus | 1 | 2023 | 22 | 0.050 |
Why?
|
| Anastomosis, Surgical | 4 | 2007 | 982 | 0.050 |
Why?
|
| Netherlands | 2 | 2020 | 2222 | 0.050 |
Why?
|
| Eisenmenger Complex | 1 | 2003 | 26 | 0.050 |
Why?
|
| Sample Size | 1 | 2006 | 843 | 0.050 |
Why?
|
| Databases as Topic | 3 | 2011 | 473 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2011 | 1818 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9187 | 0.050 |
Why?
|
| Massachusetts | 4 | 2019 | 8837 | 0.050 |
Why?
|
| Kidney | 1 | 2018 | 7033 | 0.050 |
Why?
|
| Normal Distribution | 2 | 1994 | 272 | 0.050 |
Why?
|
| Lactates | 1 | 2023 | 401 | 0.050 |
Why?
|
| Electrolytes | 1 | 2023 | 274 | 0.050 |
Why?
|
| Athetosis | 1 | 2002 | 15 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3031 | 0.050 |
Why?
|
| Prolapse | 1 | 2022 | 63 | 0.050 |
Why?
|
| Weight Lifting | 1 | 2023 | 130 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 4420 | 0.050 |
Why?
|
| Child Behavior Disorders | 1 | 2007 | 804 | 0.050 |
Why?
|
| Seizures | 2 | 2006 | 2965 | 0.050 |
Why?
|
| Equipment Failure | 3 | 2014 | 580 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2007 | 704 | 0.050 |
Why?
|
| Histocompatibility Testing | 1 | 2024 | 716 | 0.050 |
Why?
|
| Preoperative Care | 3 | 2013 | 2241 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2010 | 2640 | 0.050 |
Why?
|
| Epoprostenol | 1 | 2003 | 248 | 0.050 |
Why?
|
| Steroids | 2 | 2023 | 929 | 0.050 |
Why?
|
| Hypertrophy, Right Ventricular | 2 | 2018 | 109 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 3366 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2006 | 1336 | 0.050 |
Why?
|
| Cognition Disorders | 3 | 2007 | 3976 | 0.050 |
Why?
|
| Family Relations | 1 | 2004 | 317 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5665 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2006 | 634 | 0.050 |
Why?
|
| Cardiology Service, Hospital | 1 | 2003 | 240 | 0.050 |
Why?
|
| Anthracyclines | 1 | 2023 | 285 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2004 | 316 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7865 | 0.050 |
Why?
|
| Body Surface Area | 3 | 2013 | 197 | 0.050 |
Why?
|
| Fluoroscopy | 2 | 2021 | 947 | 0.050 |
Why?
|
| Cattle | 2 | 2019 | 3818 | 0.050 |
Why?
|
| Acute Disease | 3 | 2023 | 7226 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 2133 | 0.040 |
Why?
|
| Lymphadenitis | 1 | 2021 | 99 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1182 | 0.040 |
Why?
|
| Organizational Culture | 2 | 2014 | 509 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 1241 | 0.040 |
Why?
|
| Body Mass Index | 4 | 2019 | 12952 | 0.040 |
Why?
|
| Reference Values | 4 | 2013 | 4921 | 0.040 |
Why?
|
| Catheters | 1 | 2023 | 426 | 0.040 |
Why?
|
| Diagnosis, Differential | 4 | 2021 | 12976 | 0.040 |
Why?
|
| Conjunctivitis | 1 | 2021 | 155 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2023 | 736 | 0.040 |
Why?
|
| Insurance, Health | 2 | 2009 | 2493 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2022 | 278 | 0.040 |
Why?
|
| Patient Readmission | 2 | 2023 | 3265 | 0.040 |
Why?
|
| Potassium | 1 | 2023 | 1309 | 0.040 |
Why?
|
| Infusions, Intravenous | 3 | 2014 | 2217 | 0.040 |
Why?
|
| Coronary Care Units | 1 | 2021 | 235 | 0.040 |
Why?
|
| Cognition | 2 | 2014 | 6988 | 0.040 |
Why?
|
| Radiation Dosage | 2 | 2021 | 1962 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4340 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2005 | 809 | 0.040 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 5333 | 0.040 |
Why?
|
| Telemetry | 1 | 2020 | 199 | 0.040 |
Why?
|
| Risk | 3 | 2020 | 9616 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 781 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2023 | 2643 | 0.040 |
Why?
|
| Gross Domestic Product | 1 | 2019 | 77 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 1668 | 0.040 |
Why?
|
| Physicians | 1 | 2017 | 4584 | 0.040 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 83 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 2 | 2007 | 2642 | 0.040 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 14610 | 0.040 |
Why?
|
| Attitude of Health Personnel | 3 | 2019 | 3885 | 0.040 |
Why?
|
| Health Services Accessibility | 2 | 2009 | 5426 | 0.040 |
Why?
|
| Mouth Mucosa | 1 | 2021 | 432 | 0.040 |
Why?
|
| Platelet Count | 1 | 2021 | 782 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2010 | 3571 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2017 | 2489 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4487 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2014 | 10756 | 0.040 |
Why?
|
| Sodium | 1 | 2023 | 1589 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2001 | 590 | 0.040 |
Why?
|
| Models, Biological | 1 | 1994 | 9458 | 0.040 |
Why?
|
| Heart Valves | 1 | 2020 | 284 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2013 | 1636 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2023 | 709 | 0.040 |
Why?
|
| Child Nutrition Disorders | 1 | 2019 | 139 | 0.040 |
Why?
|
| Health Status | 4 | 2006 | 4077 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 5114 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2005 | 1490 | 0.040 |
Why?
|
| Selectins | 1 | 1997 | 101 | 0.040 |
Why?
|
| Cerebellum | 1 | 2005 | 1501 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 1812 | 0.040 |
Why?
|
| Sternum | 1 | 2018 | 175 | 0.040 |
Why?
|
| Pyridones | 1 | 2023 | 809 | 0.040 |
Why?
|
| Canada | 2 | 2013 | 2125 | 0.040 |
Why?
|
| Social Behavior | 1 | 2004 | 1136 | 0.040 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2017 | 40 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2021 | 1597 | 0.040 |
Why?
|
| Fee Schedules | 2 | 2013 | 87 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 260 | 0.030 |
Why?
|
| Radiography | 4 | 2013 | 6974 | 0.030 |
Why?
|
| Sports | 1 | 2023 | 705 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2023 | 1738 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2008 | 6392 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2021 | 616 | 0.030 |
Why?
|
| Animals | 10 | 2022 | 168089 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 2746 | 0.030 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2017 | 93 | 0.030 |
Why?
|
| Pakistan | 1 | 2017 | 292 | 0.030 |
Why?
|
| Educational Status | 1 | 2024 | 2510 | 0.030 |
Why?
|
| Private Sector | 1 | 2019 | 394 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2052 | 0.030 |
Why?
|
| Europe | 2 | 2013 | 3423 | 0.030 |
Why?
|
| Carbon Dioxide | 2 | 2014 | 1147 | 0.030 |
Why?
|
| Syncope | 1 | 2019 | 428 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2017 | 510 | 0.030 |
Why?
|
| Stroke | 1 | 2018 | 9721 | 0.030 |
Why?
|
| Financing, Government | 1 | 2019 | 472 | 0.030 |
Why?
|
| Medical Audit | 1 | 2017 | 452 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2017 | 188 | 0.030 |
Why?
|
| Endocarditis | 1 | 2020 | 349 | 0.030 |
Why?
|
| Poverty | 2 | 2022 | 2691 | 0.030 |
Why?
|
| Standard of Care | 1 | 2019 | 550 | 0.030 |
Why?
|
| Abortion, Eugenic | 1 | 2015 | 39 | 0.030 |
Why?
|
| Antibodies | 1 | 2023 | 2415 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2019 | 848 | 0.030 |
Why?
|
| Hypotension | 1 | 2021 | 879 | 0.030 |
Why?
|
| Electroencephalography | 3 | 2006 | 6242 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2021 | 716 | 0.030 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2015 | 69 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 565 | 0.030 |
Why?
|
| Glucose | 2 | 2023 | 4342 | 0.030 |
Why?
|
| Medicaid | 2 | 2013 | 2813 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 691 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 801 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2021 | 1067 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 1997 | 252 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2014 | 245 | 0.030 |
Why?
|
| Warfarin | 1 | 2023 | 1482 | 0.030 |
Why?
|
| Comorbidity | 4 | 2012 | 10516 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7400 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1999 | 951 | 0.030 |
Why?
|
| Random Allocation | 2 | 2000 | 2393 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2023 | 2137 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2003 | 2026 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 637 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1997 | 1128 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2019 | 825 | 0.030 |
Why?
|
| Homosexuality | 1 | 1994 | 267 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2015 | 12341 | 0.030 |
Why?
|
| Diastole | 1 | 2016 | 782 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2002 | 1201 | 0.030 |
Why?
|
| Image Enhancement | 2 | 2014 | 2888 | 0.030 |
Why?
|
| Neurologic Examination | 2 | 2007 | 915 | 0.030 |
Why?
|
| Alagille Syndrome | 1 | 2013 | 45 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1390 | 0.030 |
Why?
|
| Action Potentials | 1 | 2020 | 1830 | 0.030 |
Why?
|
| Pandemics | 2 | 2023 | 8663 | 0.030 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2014 | 379 | 0.030 |
Why?
|
| Internationality | 1 | 2018 | 999 | 0.030 |
Why?
|
| Energy Intake | 2 | 2006 | 2133 | 0.030 |
Why?
|
| Manometry | 1 | 2015 | 453 | 0.030 |
Why?
|
| Infant Behavior | 1 | 2013 | 156 | 0.030 |
Why?
|
| Italy | 1 | 1994 | 844 | 0.030 |
Why?
|
| Tidal Volume | 1 | 2014 | 488 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5493 | 0.030 |
Why?
|
| Selection Bias | 1 | 1994 | 359 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 1496 | 0.020 |
Why?
|
| Patient Selection | 2 | 2014 | 4246 | 0.020 |
Why?
|
| Body Height | 1 | 2018 | 1566 | 0.020 |
Why?
|
| Forecasting | 2 | 2015 | 2928 | 0.020 |
Why?
|
| Child Welfare | 2 | 2008 | 521 | 0.020 |
Why?
|
| Platinum | 1 | 2013 | 220 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2020 | 901 | 0.020 |
Why?
|
| Mass Screening | 1 | 2007 | 5426 | 0.020 |
Why?
|
| Geriatrics | 1 | 2016 | 387 | 0.020 |
Why?
|
| Pain | 2 | 2020 | 5072 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2012 | 284 | 0.020 |
Why?
|
| Inflammation | 2 | 2014 | 10759 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 1994 | 991 | 0.020 |
Why?
|
| Sheep | 2 | 2007 | 1436 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1624 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 3691 | 0.020 |
Why?
|
| Hepatomegaly | 1 | 2010 | 84 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2023 | 3422 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 1674 | 0.020 |
Why?
|
| Anthropometry | 2 | 2006 | 1338 | 0.020 |
Why?
|
| History, 19th Century | 1 | 1993 | 718 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 823 | 0.020 |
Why?
|
| Nursing Service, Hospital | 1 | 2010 | 17 | 0.020 |
Why?
|
| Texas | 1 | 2011 | 403 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2013 | 911 | 0.020 |
Why?
|
| Hospital Information Systems | 1 | 2013 | 394 | 0.020 |
Why?
|
| Wound Healing | 1 | 2001 | 2800 | 0.020 |
Why?
|
| Models, Economic | 1 | 2014 | 714 | 0.020 |
Why?
|
| Myofibroblasts | 1 | 2011 | 223 | 0.020 |
Why?
|
| Motor Skills | 1 | 2013 | 521 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1994 | 529 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2004 | 2421 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 2380 | 0.020 |
Why?
|
| Insurance Carriers | 1 | 2011 | 155 | 0.020 |
Why?
|
| Infection Control | 1 | 2017 | 983 | 0.020 |
Why?
|
| Confidence Intervals | 2 | 2008 | 2928 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1498 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2013 | 630 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2019 | 1369 | 0.020 |
Why?
|
| Eye Protective Devices | 1 | 2009 | 33 | 0.020 |
Why?
|
| Apgar Score | 1 | 2009 | 126 | 0.020 |
Why?
|
| Lubricants | 1 | 2009 | 26 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2010 | 411 | 0.020 |
Why?
|
| Professional Competence | 1 | 2012 | 430 | 0.020 |
Why?
|
| Retreatment | 1 | 2010 | 598 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 11476 | 0.020 |
Why?
|
| Cost Savings | 1 | 2014 | 911 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 4014 | 0.020 |
Why?
|
| Phenotype | 2 | 2019 | 16575 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 854 | 0.020 |
Why?
|
| Radiology, Interventional | 1 | 2013 | 477 | 0.020 |
Why?
|
| Neutrophils | 1 | 2021 | 3763 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 20588 | 0.020 |
Why?
|
| Research Design | 2 | 2016 | 6180 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2014 | 947 | 0.020 |
Why?
|
| Platelet Factor 4 | 1 | 2008 | 129 | 0.020 |
Why?
|
| Labor, Obstetric | 1 | 2011 | 323 | 0.020 |
Why?
|
| Birth Weight | 2 | 2007 | 2104 | 0.020 |
Why?
|
| Classification | 1 | 2008 | 128 | 0.020 |
Why?
|
| Hyperemia | 1 | 2009 | 225 | 0.020 |
Why?
|
| Anaerobic Threshold | 1 | 2007 | 51 | 0.020 |
Why?
|
| Parturition | 1 | 2011 | 447 | 0.020 |
Why?
|
| Atrial Septum | 1 | 2007 | 60 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2009 | 366 | 0.020 |
Why?
|
| Guatemala | 1 | 2007 | 159 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2008 | 573 | 0.020 |
Why?
|
| Blood Volume | 1 | 2008 | 547 | 0.020 |
Why?
|
| Constitution and Bylaws | 1 | 2006 | 4 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3923 | 0.020 |
Why?
|
| Brain | 3 | 2008 | 27094 | 0.020 |
Why?
|
| Genotype | 2 | 2014 | 12985 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 18222 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 710 | 0.020 |
Why?
|
| Resource Allocation | 1 | 2009 | 350 | 0.020 |
Why?
|
| Professional Practice | 1 | 2008 | 313 | 0.020 |
Why?
|
| Prosthesis Implantation | 2 | 2001 | 590 | 0.020 |
Why?
|
| Fingers | 1 | 2009 | 506 | 0.020 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2008 | 407 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 958 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2009 | 350 | 0.020 |
Why?
|
| Drug-Eluting Stents | 1 | 2012 | 681 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2010 | 1139 | 0.020 |
Why?
|
| Health Surveys | 2 | 2006 | 4037 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1993 | 2765 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2008 | 850 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 808 | 0.020 |
Why?
|
| Safety | 1 | 2009 | 1151 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2004 | 117 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 2009 | 659 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1994 | 2189 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3805 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 763 | 0.010 |
Why?
|
| Drainage | 1 | 2010 | 1157 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2007 | 737 | 0.010 |
Why?
|
| Infant Nutrition Disorders | 1 | 2004 | 70 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2008 | 1391 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 8002 | 0.010 |
Why?
|
| Motor Activity | 1 | 2013 | 2712 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 1780 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 740 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2003 | 80 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 290 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8998 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2004 | 281 | 0.010 |
Why?
|
| Embolism | 1 | 2006 | 399 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11067 | 0.010 |
Why?
|
| Electrodes | 1 | 2005 | 611 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 2007 | 707 | 0.010 |
Why?
|
| Minority Groups | 1 | 2009 | 1201 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2008 | 944 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 2003 | 293 | 0.010 |
Why?
|
| Psychological Tests | 1 | 2004 | 639 | 0.010 |
Why?
|
| Seasons | 1 | 2007 | 1518 | 0.010 |
Why?
|
| Pressure | 1 | 2004 | 1155 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2006 | 981 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 1762 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 1122 | 0.010 |
Why?
|
| Central Venous Pressure | 1 | 2000 | 79 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 7407 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 1375 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 1331 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2011 | 2923 | 0.010 |
Why?
|
| Corrosion Casting | 1 | 2000 | 15 | 0.010 |
Why?
|
| Social Adjustment | 1 | 2003 | 632 | 0.010 |
Why?
|
| Silicone Elastomers | 1 | 2000 | 78 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2004 | 675 | 0.010 |
Why?
|
| Fasting | 1 | 2006 | 1603 | 0.010 |
Why?
|
| Metabolic Diseases | 1 | 2006 | 680 | 0.010 |
Why?
|
| Fetal Development | 1 | 2005 | 768 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2000 | 439 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2000 | 503 | 0.010 |
Why?
|
| Lung | 1 | 2018 | 9979 | 0.010 |
Why?
|
| Internet | 1 | 2011 | 3096 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 1304 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2009 | 3549 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2004 | 1525 | 0.010 |
Why?
|
| Counseling | 1 | 2006 | 1536 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2003 | 1736 | 0.010 |
Why?
|
| Aneurysm | 1 | 2001 | 337 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2003 | 934 | 0.010 |
Why?
|
| Medicare Part B | 1 | 1998 | 117 | 0.010 |
Why?
|
| Sinoatrial Node | 1 | 1997 | 99 | 0.010 |
Why?
|
| Perinatal Care | 1 | 1999 | 244 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1791 | 0.010 |
Why?
|
| Child Behavior | 1 | 2002 | 848 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2003 | 1303 | 0.010 |
Why?
|
| Patient Transfer | 1 | 2003 | 794 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 3089 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10423 | 0.010 |
Why?
|
| India | 1 | 2002 | 2287 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2010 | 9319 | 0.010 |
Why?
|
| Medicare | 1 | 2013 | 6774 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2007 | 3239 | 0.010 |
Why?
|
| Insulin | 1 | 2008 | 6588 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2000 | 1250 | 0.010 |
Why?
|
| Smoking | 1 | 2010 | 9055 | 0.010 |
Why?
|
| Obesity | 2 | 2006 | 12940 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58952 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3407 | 0.010 |
Why?
|
| Reimbursement Mechanisms | 1 | 1998 | 667 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 2632 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 4052 | 0.010 |
Why?
|
| Health Services Research | 1 | 1998 | 1807 | 0.010 |
Why?
|
| Pneumonia | 1 | 2002 | 2142 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2005 | 6635 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 30004 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 8519 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 5775 | 0.000 |
Why?
|
| HIV Infections | 1 | 1994 | 17348 | 0.000 |
Why?
|
| Mice | 1 | 2003 | 81330 | 0.000 |
Why?
|